
### [MONDO:0016631](http://purl.obolibrary.org/obo/MONDO_0016631)
**Label:** rare hemorrhagic disorder due to an acquired platelet anomaly

**Subclasses:** [MONDO:0018735](http://purl.obolibrary.org/obo/MONDO_0018735) (multifocal lymphangioendotheliomatosis-thrombocytopenia syndrome), [MONDO:0018702](http://purl.obolibrary.org/obo/MONDO_0018702) (TAFRO syndrome), [MONDO:0019415](http://purl.obolibrary.org/obo/MONDO_0019415) (fetal and neonatal alloimmune thrombocytopenia), [MONDO:0008585](http://purl.obolibrary.org/obo/MONDO_0008585) (HELLP syndrome), [MONDO:0016030](http://purl.obolibrary.org/obo/MONDO_0016030) (Evans syndrome), [MONDO:0007708](http://purl.obolibrary.org/obo/MONDO_0007708) (Kasabach-Merritt syndrome), [MONDO:0019098](http://purl.obolibrary.org/obo/MONDO_0019098) (autoimmune thrombocytopenia), [MONDO:0014414](http://purl.obolibrary.org/obo/MONDO_0014414) (STAT3-related early-onset multisystem autoimmune disease), [MONDO:0008558](http://purl.obolibrary.org/obo/MONDO_0008558) (autoimmune thrombocytopenic purpura), 

**Corr. equiv. classes:** [OMIM:189800](http://purl.obolibrary.org/obo/OMIM_189800), [Orphanet:1959](http://www.orpha.net/ORDO/Orphanet_1959), [OMIM:188030](http://purl.obolibrary.org/obo/OMIM_188030), [Orphanet:438159](http://www.orpha.net/ORDO/Orphanet_438159), [Orphanet:244242](http://www.orpha.net/ORDO/Orphanet_244242), [Orphanet:457077](http://www.orpha.net/ORDO/Orphanet_457077), [Orphanet:2330](http://www.orpha.net/ORDO/Orphanet_2330), [OMIM:615952](http://purl.obolibrary.org/obo/OMIM_615952), [OMIM:141000](http://purl.obolibrary.org/obo/OMIM_141000), [Orphanet:3002](http://www.orpha.net/ORDO/Orphanet_3002), [Orphanet:71203](http://www.orpha.net/ORDO/Orphanet_71203), [Orphanet:464321](http://www.orpha.net/ORDO/Orphanet_464321), [Orphanet:853](http://www.orpha.net/ORDO/Orphanet_853), 

**Class expressions from DL-Learner:**

- [HP:0001873](http://purl.obolibrary.org/obo/HP_0001873) (Thrombocytopenia) 30.70%
- [HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count) 30.48%
- [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) 30.11%
- [HP:0001873](http://purl.obolibrary.org/obo/HP_0001873) (Thrombocytopenia) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) 27.60%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 26.28%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 24.33%
- Thing 24.32%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 24.32%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0001873](http://purl.obolibrary.org/obo/HP_0001873) (Thrombocytopenia) 23.52%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count) 23.27%
- [HP:0001873](http://purl.obolibrary.org/obo/HP_0001873) (Thrombocytopenia) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 22.99%
- [HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 22.76%
- [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) 18.43%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 17.29%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 17.27%


